Julian Peter Müller

5PUBLICATIONS
8CO-AUTHORS
Dental therapeutics, pharmacology and toxicologyPharmacogenomicsPredictive and prognostic markersMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 02, 2026
Rudolf Buchheim Award 2026: solanidine as a dietary derived CYP2D6 biomarker.

|Feb 04, 2026
Pharmacogenetic CYP2B6 variants affect steroid hormone metabolism in human breast cancer cells.

Marco Hoffmann, Julian Peter Müller, Stefan Düsterhöft

|Feb 17, 2025
Solanidine-derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patients.

Jens Andreas Sarömba, Julian Peter Müller, Jolanta Tupiec

|Nov 16, 2023
Nutrimetric Validation of Solanidine as Dietary-Derived CYP2D6 Activity Marker In Vivo.

Julian Peter Müller, Jens Sarömba, Patrick Ziegler

Pageof 1